Cite
HARVARD Citation
Hein, A. et al. (n.d.). Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study. International journal of cancer. 137 (12), pp. 2981-2988. [Online].